The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.

[1]  K. Hübner,et al.  Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. , 1996, Journal of hepatology.

[2]  E. Dickson,et al.  Time course of histological progression in primary biliary cirrhosis , 1996, Hepatology.

[3]  G. Gores,et al.  The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study , 1995, Hepatology.

[4]  S. Sherlock.  Therapeutic trials in primary biliary cirrhosis. , 1994, QJM : monthly journal of the Association of Physicians.

[5]  T. Warnes,et al.  Primary biliary cirrhosis: how should we evaluate new treatments? , 1994, The Lancet.

[6]  B. Balkau,et al.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.

[7]  D G Altman,et al.  Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. , 1993, Gastroenterology.

[8]  M. Kaplan,et al.  Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. , 1991, Gastroenterology.

[9]  J. Hoofnagle,et al.  Methotrexate therapy of primary biliary cirrhosis: promising but worrisome. , 1991, Gastroenterology.

[10]  B. Balkau,et al.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.

[11]  A. Roda,et al.  Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: A dose‐response study , 1991, Hepatology.

[12]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[13]  H. Frenzel,et al.  Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. , 1989, The Journal of rheumatology.

[14]  M. Kaplan,et al.  Primary biliary cirrhosis treated with low-dose oral pulse methotrexate. , 1988, Annals of internal medicine.

[15]  P. Grambsch,et al.  Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis , 1988, Hepatology.

[16]  Y. Chrétien,et al.  IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? , 1987, The Lancet.

[17]  J. Neuberger,et al.  Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. , 1985, Gastroenterology.

[18]  J. Boyer,et al.  The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. , 1983, The New England journal of medicine.

[19]  U. Leuschner.  Ursodeoxycholic acid therapy in primary biliary cirrhosis. , 1994, Scandinavian journal of gastroenterology. Supplement.

[20]  F. Callea,et al.  The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis: A 12-month double-blind, placebo-controlled trial , 1994 .

[21]  W. Gerok,et al.  Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. , 1993, Journal of hepatology.

[22]  F. Callea,et al.  Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial. , 1993, Journal of hepatology.

[23]  H. Zachariae,et al.  Methotrexate-induced liver cirrhosis. A follow-up. , 1987, Dermatologica.

[24]  A. H. Mackenzie.  Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis. , 1985, Cleveland Clinic quarterly.

[25]  David C. Jones,et al.  HEPATOLOGY Elsewhere , 2022 .